American Journal Of HematologySCIE

文章摘录

• Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia Author: Wang, Qian; Cai, Wen-zhi; Wang, Qin-rong; Zhu, Ming-qing; Yan, Ling-zhi; Yu, Yan; Bao, Xie-bing; Shen, Hong-jie; Yao, Hong; Xie, Jun-dan; Zhang, Tong-tong; Zhang, Ling; Xu, Xiao-yu; Shan, Zhe; Liu, Hong; Cen, Jian-nong; Liu, Dan-dan; Pan, Jin-lan; Lu, Da-ru; Chen, Jia; Xu, Yang; Zhang, Ri; Wang, Ying; Xue, Sheng-li; Miao, Miao; Han, Yue; Tang, Xiao-wen; Qiu, Hui-ying; Sun, Ai-ning; Huang, Jin-yan; Dai, Hai-ping; Wu, De-pei; Chen, Su-ning Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 1, pp. 66-78. DOI: 10.1002/ajh.26758
• Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma Author: Yang, Peiyu; Chen, Haimin; Liang, Xinyue; Xu, Weiling; Yu, Shanshan; Huang, Wenyang; Yi, Xingcheng; Guo, Qiang; Tian, Mengru; Yue, Tingting; Li, Mengyao; Zhang, Yingjie; Zhang, Mengxue; Yan, Yurong; Hu, Zhongli; Kumar, Shaji K.; Zhou, Fan; Dai, Yun; Jin, Fengyan Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 2, pp. 251-263. DOI: 10.1002/ajh.26774
• Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT: An open-label, multicenter, randomized phase 3 trial Author: Liu, Hui; Huang, Fen; Zhang, Yu; Wu, Meiqing; Xu, Na; Fan, Zhiping; Sun, Zhiqiang; Li, Xudong; Lin, Dongjun; Xiong, Yiying; Liu, Xiaodan; Lin, Ren; Shi, Pengcheng; Xu, Jun; Wang, Zhixiang; Li, Xiaofang; Sun, Jing; Liu, Qifa; Xuan, Li Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 3, pp. 408-412. DOI: 10.1002/ajh.26800
• The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases Author: Cao, Yigeng; Gong, Xiaowen; Feng, Yahui; Wang, Mingyang; Hu, Yu; Liu, Huilan; Liu, Xueou; Qi, Saibing; Ji, Yanping; Liu, Fang; Zhu, Huaiping; Guo, Wenwen; Shen, Qiujin; Zhang, Rongli; Zhao, Ningning; Zhai, Weihua; Song, Xiaoqiang; Chen, Xin; Geng, Liangquan; Zheng, Xuetong; Ma, Qiaoling; Tang, Baolin; Wei, Jialin; Huang, Yong; Ren, Yuanyuan; Song, Kaidi; Yang, Donglin; Pang, Aiming; Yao, Wen; He, Yi; Shang, Yue; Wan, Xiang; Zhang, Wei; Zhang, Song; Sun, Guangyu; Feng, Sizhou; Zhu, Xiaofan; Han, Mingzhe; Song, Zhen; Guo, Ye; Sun, Zimin; Jiang, Erlie; Chen, Junren Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 2, pp. 309-321. DOI: 10.1002/ajh.26792
• Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study Author: Cui, Lei; Wang, Chan-Juan; Lian, Hong-Yun; Zhang, Li; Ma, Hong-Hao; Wang, Dong; Chen, Fen-Fen; Zhang, Qing; Yang, Ying; Wei, Ang; Huang, Xiao-Tong; Zhu, Ting; Wang, Tian-You; Li, Zhi-Gang; Zhang, Rui Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 4, pp. 598-607. DOI: 10.1002/ajh.26829
• Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study Author: Xu, Wei; Zhou, Keshu; Wang, Tingyu; Yang, Shenmiao; Liu, Lihong; Hu, Yu; Zhang, Wei; Ding, Kaiyang; Zhou, Jianfeng; Gao, Sujun; Xu, Bing; Zhu, Zunmin; Liu, Ting; Zhang, Huilai; Hu, Jianda; Ji, Chunyan; Wang, Shunqing; Xia, Zhongjun; Wang, Xin; Li, Yan; Song, Yongping; Ma, Shuo; Tang, Xinran; Zhang, Bin; Li, Jianyong Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 4, pp. 571-579. DOI: 10.1002/ajh.26826
• Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial Author: Qiu, Kun-yin; Wang, Jia-yi; Huang, Li-bin; Li, Chang-gang; Xu, Lu-hong; Liu, Ri-yang; Chen, Hui-qin; Ruan, Yong-sheng; Zhen, Zi-jun; Li, Chi-kong; Fang, Jian-pei Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26910
• Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation Author: Tang, Yaqiong; Zhang, Ziyan; Liu, Silu; Yao, Yifang; Pan, Tingting; Qi, Jiaqian; Kang, Huizhu; Liu, Yuejun; Cai, Chengsen; Zhou, Meng; He, Xuefeng; Hu, Xiaohui; Ma, Xiao; Wu, Depei; Han, Yue Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26903